Ministry of Health and Family Welfare

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The Ministry of Health and Family Welfare is an Indian government ministry charged with health policy in India. It is also responsible for all government programs relating to family planning in India.

The Minister of Health and Family Welfare holds cabinet rank as a member of the Council of Ministers. The current minister is Shri. Ghulam Nabi Azad,[1] who is assisted by a Minister of States for Health and Family Welfare, Shri. Abu Hasem Khan Choudhury & Shri. S. Gandhiselvan. The Ministry regularly publishes the Indian Pharmacopoeia since 1955 through Indian Pharmacopoeia Commission (IPC) an autonomous body under the ministry for setting of standards for drugs, pharmaceuticals and healthcare devices and technologies in India.[2]


The ministry is composed of four departments: Health & Family Welfare; Health Research; AIDS Control; and Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH).[3]

Department of Health[edit]

The Department of Health deals with health care, including awareness campaigns, immunization campaigns, preventive medicine, and public health. Bodies under the administrative control of this department are:

Department of Family Welfare[edit]

The Department of Family Welfare (FW) is responsible for aspects relating to family welfare, especially in reproductive health, maternal health, pediatrics, information, education and communications; cooperation with NGOs and international aid groups; and rural health services. The Department of Family Welfare is responsible for:

Department of AYUSH[edit]

The Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) deals with ayurveda (Indian traditional medicine), yoga, naturopathy, unani, siddha, and homoeopathy, and other alternative medicine systems.

The department was established in March 1995 as the Department of Indian Systems of Medicines and Homoeopathy (ISM&H). The department is charged with upholding education standards in the Indian Systems of Medicines and Homoeopathy colleges, strengthening research, promoting the cultivation of medicinal plants used, and working on Pharmacopoeia standards. Bodies under the control of the Department of AYUSH are:


The Ministry on June 18 decided to suspend a diabetes treatment drug, pioglitazone,and its combinations following reports of its suspected links to increased risk of cancer and heart failure.[4] The only data the ministry relied on to ban invoke the ban was - eight ‘cases’ of bladder cancer in patients who are on pioglitazone. But, the ban was revoked in less than a month's time with the ban being replaced with a box warning.The unscientific methods for invoking and revoking have come under criticism .[5]


External links[edit]